Dietary therapy for drug-resistant childhood epilepsy can be difficult for families to maintain. This randomized controlled trial compared a standard daily low-glycemic index treatment with an intermittent approach that allowed a more liberal diet on two days each week. Children in both groups experienced substantial seizure-frequency reduction over 24 weeks. The primary comparison showed that intermittent therapy was comparable with daily therapy, while caregiver difficulty was significantly lower in the intermittent group. This finding is clinically relevant because adherence is one of the major practical barriers to dietary treatment. A less restrictive schedule may improve feasibility without necessarily sacrificing seizure control. The study does not establish that intermittent therapy should replace established ketogenic or low-glycemic protocols for every child; treatment still requires specialist dietetic supervision, careful nutritional planning and monitoring of individual response. For HCPs, the paper illustrates a broader principle in epilepsy care: effectiveness depends not only on biological efficacy but also on whether the treatment can be sustained by the patient and family. Individualising dietary therapy around family capacity may improve long-term engagement while preserving a clinically meaningful reduction in seizure burden.